Ulipristal versus Levonorgestrel for Emergency Contraception: A Review of Comparative Cost-Effectiveness [Internet]

Review
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Feb 12.
CADTH Rapid Response Reports.

Excerpt

A previous CADTH report reviewed the comparative clinical effectiveness and guidelines on the emergency contraception (EC) use of ulipristal acetate versus levonorgestrel. The aim of this report is to review the comparative cost-effectiveness of those two EC drugs.

Publication types

  • Review

Grants and funding

Funding: CADTH receives funding from Canada’s federal, provincial, and territorial governments, with the exception of Quebec.